Siamoglou Stavroula, Koromina Maria, Moy Foong-Ming, Mitropoulou Christina, Patrinos George P, Vasileiou Konstantinos
Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.
Department of Social and Preventive Medicine, Faculty of Medicine, Julius Centre University of Malaya, Kuala Lumpur, Malaysia.
OMICS. 2021 Jan;25(1):52-59. doi: 10.1089/omi.2020.0178. Epub 2020 Nov 10.
This study reports on the attitudes and perceptions toward pharmacogenomics (PGx) and personalized medicine (PM) education among pharmacy and medical students in Malaysian health sciences. Importantly, the survey was developed through a codesign approach, with field pretesting/design with users before the actual survey, and based on collaboration between institutions in Greece and Malaysia. The study addressed eight key areas of interest to education in health sciences: (1) General awareness about genetics and PGx, (2) Attitude toward genetic testing usefulness, (3) Benefits of direct-to-consumer personal genome testing as a "diagnostic" tool, (4) Concerns (risks) about genetics, (5) Effectiveness of genetic testing in PM, (6) Benefits of PGx on disease management, (7) Benefits of PGx on drug management, and (8) Attitudes toward genetic testing public endorsement. We observed that Malaysian students appear aware of the term PGx, but there are areas of critical knowledge gap such as the need for greater familiarity with the concept of PGx implementation science, and the availability of genetic testing in clinical practice. This is one of the first studies on perceptions and attitudes toward PGx testing in Southeast Asia. The present findings provide a map of the views and perspectives of medicine and pharmacy students regarding PGx and implementation of PM in Malaysia and should assist toward facilitating the integration of genomics into the medical decision-making process. To this end, it is necessary to enhance collaboration between universities, health care institutions, and governing bodies to incorporate further training and additional education topics related to PGx and genetic testing. This is the first study that assesses the level of PGx and genomics knowledge of pharmacy and medicine students in Southeast Asia, Malaysia in particular, and thus paves the way to guide future global PGx implementation science.
本研究报告了马来西亚健康科学领域药学和医学专业学生对药物基因组学(PGx)和个性化医疗(PM)教育的态度与认知。重要的是,该调查是通过一种协同设计方法开展的,在实际调查之前进行了实地预测试/与用户共同设计,并且基于希腊和马来西亚机构之间的合作。该研究涉及健康科学教育的八个关键兴趣领域:(1)对遗传学和PGx的总体认知,(2)对基因检测有用性的态度,(3)直接面向消费者的个人基因组检测作为“诊断”工具的益处,(4)对遗传学的担忧(风险),(5)基因检测在个性化医疗中的有效性,(6)PGx对疾病管理的益处,(7)PGx对药物管理的益处,以及(8)对基因检测公众认可的态度。我们观察到马来西亚学生似乎知晓PGx这个术语,但在关键知识领域存在差距,比如需要更熟悉PGx实施科学的概念,以及临床实践中基因检测的可及性。这是东南亚地区关于对PGx检测的认知和态度的首批研究之一。目前的研究结果提供了医学和药学专业学生对马来西亚PGx及个性化医疗实施的观点和看法图谱,应有助于促进基因组学融入医疗决策过程。为此,有必要加强大学、医疗机构和管理机构之间的合作,纳入与PGx和基因检测相关的进一步培训及其他教育主题。这是第一项评估东南亚地区,尤其是马来西亚药学和医学专业学生的PGx和基因组学知识水平的研究,从而为指导未来全球PGx实施科学铺平了道路。